Aptose Biosciences Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 9 - Lease Liability

Note 9 - Lease Liability

3 Months Ended

Mar. 31, 2025

The Company leases office space in San Diego, California pursuant to a lease agreement that is scheduled to expire on May 31, 2026. The Company leased office space in Toronto, Ontario, Canada, which expired on June 30, 2024. The Company has not included any extension periods in calculating its right-of-use assets and lease liabilities. The Company also enters into leases for small office equipment.

Minimum payments, undiscounted, under our operating leases are as follows:


Years ending December 31,	Amount
2025	$	350
2026		197
Total minimum lease payments		547
Less: imputed interest		(26	)
Present value of lease liabilities		521
Less: current portion of lease liability		(441	)
Lease liability, non-current	$	80

The following table presents the weighted average remaining term of the leases and the weighted average discount rate:


	March 31, 2025			December 31, 2024
Weighted-average remaining term – operating leases (years)		1.2			1.4
Weighted-average discount rate – operating leases		7.90	%		7.90	%

Lease liability, current portion	$	441		$	428
Lease liability, long-term portion		80			193
Total	$	521		$	621

Operating lease costs and operating cash flows from our operating leases are as follows:


	Three months ended March 31,
	2025		2024
Operating lease cost	$	107	$	112
Operating cash flows from operating leases	$	113	$	115